MedTrace Logo

Medication Abortion With Autonomous Self-Assessment Project

NCT05278780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-01-27

No results posted yet for this study

Summary

In this study, the investigators propose to create and pilot-test an asynchronous medication abortion provision service.

Conditions

  • Abortion Early

Interventions

OTHER

Screening for eligibility

Asynchronous screening

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER

  • Planned Parenthood of the Rocky Mountains

    collaborator UNKNOWN

  • Planned Parenthood North Central States

    collaborator UNKNOWN

  • Gynuity Health Projects

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-03-01
Completion
2023-04-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05278780 on ClinicalTrials.gov